Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2009 Results; Teleconference and Webcast to be held on Septemb...(ce Sheet Data ...)

Date:9/8/2009

ce Sheet Data (unaudited) June 30, 2009 June 30, 2008 ASSETS Current assets: Cash and cash equivalents $4,378,662 $9,421,770 Available-for-sale investments 3,439,650 3,352,771 Accounts receivable 508,528 5,747 Prepaid expenses and other current assets 492,824 484,362 Total current assets 8,819,664 13,264,650 Property and equipment, net 3,650,783 5,128,076 Restricted cash 475,000 475,000 Other assets 254,364 257,198 Total assets $13,199,811 $19,124,924 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Capital lease obligations, current portion $87,675 $263,128 Accounts payable 206,363 635,183 Accrued expenses 1,420,741 1,666,628 Accrued compensation - 767,509 Deferred revenue, current portion 2,650,002 1,666,669 Total current liabilities 4,364,781 4,999,117 Capital lease obligations, net of current portion 33,954 121,629 Deferred rent, net of current portion 1,182,026 1,479,794 Deferred revenue, net of current portion 4,305,551 5,972,220 Total liabilities 9,886,312 12,572,760 Stockholders' equity: Preferred stock of $0.01 par value - authorized 10,000,000 shares; Series A Convertible; issued and outstanding 4,997 shares as of
'/>"/>

SOURCE Palatin Technologies, Inc. Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7
Related biology technology :

1. Palatin Technologies Announces Reacquisition of Full Rights to Bremelanotide Program
2. Palatin Technologies Refutes Competitive Technologies Contention of Material Breach
3. Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2007 Results; Teleconference and Webcast to be held on September 18, 2007
4. Palatin Technologies to Report Fiscal Year 2008 First Quarter Results; Teleconference and Webcast on November 9, 2007
5. Palatin Technologies, Inc. Reports Fiscal Year 2008 First Quarter Results; Teleconference and Webcast to be Held on November 9, 2007
6. Palatin Technologies to Report Second Quarter, Fiscal Year 2008 Financial Results; Teleconference and Webcast on February 11th
7. Palatin Technologies, Inc. Reports Positive Results of a Phase I Clinical Study With PL-3994 for the Treatment of Congestive Heart Failure
8. Palatin Technologies to Report Third Quarter, Fiscal Year 2008 Financial Results; Teleconference and Webcast on May 13th
9. Palatin Technologies Announces New Strategic Objectives and Reports Third Quarter 2008 Financial Results
10. Palatin Technologies, Inc. Reports Positive Results of Phase 2a Clinical Study with PL-3994 for the Treatment of Heart Failure
11. Palatin Technologies, Inc. Revised Call-In Number for Teleconference and Webcast to be held on September 30, 2008